Colonic hydrogen sulfide produces portal hypertension and systemic hypotension in rats

被引:22
|
作者
Huc, Tomasz [1 ]
Jurkowska, Halina [2 ]
Wrobel, Maria [2 ]
Jaworska, Kinga [1 ]
Onyszkiewicz, Maksymilian [1 ]
Ufnal, Marcin [1 ]
机构
[1] Med Univ Warsaw, Dept Expt Physiol & Pathophysiol, Lab Ctr Preclin Res, PL-02097 Warsaw, Poland
[2] Jagiellonian Univ, Chair Med Biochem, Med Coll, PL-31034 Krakow, Poland
关键词
Hydrogen sulfide; gut-derived mediators; arterial blood pressure; portal blood pressure; liver; HYPERDYNAMIC CIRCULATION; LIVER-CIRRHOSIS; H2S; BIOAVAILABILITY; VASCULATURE; RHODANESE; RESPONSES; PRESSURE; MICE;
D O I
10.1177/1535370217741869
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hydrogen sulfide, a toxic gas, at low concentrations is also a biological mediator in animals. In the colon, hydrogen sulfide is produced by intestinal tissues and gut sulfur bacteria. Gut-derived molecules undergo liver metabolism. Portal hypertension is one of the most common complications contributing to the high mortality in liver cirrhosis. We hypothesized that the colon-derived hydrogen sulfide may affect portal blood pressure. Sprague-Dawley rats were maintained either on tap water (controls) or on water solution of thioacetamide to produce liver cirrhosis (CRH-R). Hemodynamics were measured after administration of either saline or Na2S, a hydrogen sulfide donor, into (1) the colon, (2) the portal vein, or (3) the femoral vein. Expression of enzymes involved in hydrogen sulfide metabolism was measured by RT-PCR. CRH-R showed a significantly higher portal blood pressure but a lower arterial blood pressure than controls. Saline did not affect hemodynamic parameters. In controls, intracolonic hydrogen sulfide decreased arterial blood pressure and portal blood flow but increased portal blood pressure. Similarly, hydrogen sulfide administered into the portal vein decreased arterial blood pressure but increased portal blood pressure. In contrast, hydrogen sulfide administered into the systemic vein decreased both arterial and portal blood pressures. CRH-R showed significantly greater responses to hydrogen sulfide than controls. CRH-R had a significantly higher liver concentration of hydrogen sulfide but lower expression of rhodanese, an enzyme converting hydrogen sulfide to sulfate. In conclusion, colon-administered hydrogen sulfide increases portal blood pressure while decreasing the systemic arterial blood pressure. The response to hydrogen sulfide is more pronounced in cirrhotic rats which show reduced hydrogen sulfide liver metabolism. Therefore, colon-derived hydrogen sulfide may be involved in the regulation of portal blood pressure, and may contribute to portal hypertension.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 50 条
  • [31] Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension
    Sun, Yan
    Tang, Chaoshu
    Jin, Hongfang
    Du, Junbao
    BIOMOLECULES, 2022, 12 (06)
  • [32] Aluminum in total parenteral nutrition solutions produces portal inflammation in rats
    Demircan, M
    Ergun, O
    Coker, C
    Yilmaz, F
    Avanoglu, S
    Ozok, G
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 26 (03): : 274 - 278
  • [33] Hydrogen Sulfide Subchronic Treatment Improves Hypertension Induced by Traumatic Brain Injury in Rats through Vasopressor Sympathetic Outflow Inhibition
    de la Cruz, Saul Huerta
    Rocha, Luisa
    Santiago-Castaneda, Cindy
    Sanchez-Lopez, Araceli
    Pinedo-Rodriguez, Alma D.
    Medina-Terol, Grecia J.
    Centurion, David
    JOURNAL OF NEUROTRAUMA, 2022, 39 (1-2) : 181 - 195
  • [34] Restriction of Drinking Water Abrogates Splanchnic Vasodilation and Portal Hypertension in Portal Vein-Ligated Rats
    Heinemann, Akos
    Schuligoi, Rufina
    Lippe, Irmgard T.
    Stauber, Rudolf E.
    PHARMACOLOGY, 2009, 83 (01) : 26 - 32
  • [35] Emerging Roles of Hydrogen Sulfide in Inflammatory and Neoplastic Colonic Diseases
    Guo, Fang-Fang
    Yu, Ta-Chung
    Hong, Jie
    Fang, Jing-Yuan
    FRONTIERS IN PHYSIOLOGY, 2016, 7
  • [36] Hydrogen sulfide and colonic epithelial metabolism - Implications for ulcerative colitis
    Jorgensen, J
    Mortensen, PB
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (08) : 1722 - 1732
  • [37] Colonic disease in cirrhotic patients with portal hypertension - An endoscopic and clinical evaluation
    Bresci, G
    Gambardella, L
    Parisi, G
    Federici, G
    Bertini, M
    Rindi, G
    Metrangolo, S
    Tumino, E
    Bertoni, M
    Cagno, MC
    Capria, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 26 (03) : 222 - 227
  • [38] Colonic mucosal changes in Egyptian patients with liver cirrhosis and portal hypertension
    Zakaria A. Salama
    Ahmad N. Hassan
    Samar K. Darweesh
    The Egyptian Journal of Internal Medicine, 2013, 25 (4) : 196 - 201
  • [39] Hemodynamic Assessment of the Development of Portal-Systemic Collaterals in Portal Hypertensive Rats
    Chan, Che-Chang
    Tsai, Shiow-Chwen
    Cheng, Ling-Yi
    Lee, Fa-Yauh
    Lin, Han-Chieh
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (02) : 417 - 424
  • [40] Dysregulated cystathionine-β-synthase/hydrogen sulfide signaling promotes chronic stress-induced colonic hypermotility in rats
    Lin, Mengjuan
    Hu, Guiying
    Yu, Baoping
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (02):